Health Trials

Metastatic Endometrial Cancer

2

Review clinical trials related to Metastatic Endometrial Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

This is a Phase 1 study to assess the safety of ERX-315 in patients with advanced solid tumors that have failed approved systemic therapies.

Participants needed: 36
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: EtiraRx Australia Pty LtdUpdated: May 29, 2026Locations: 5
Eligibility criteria

Patients must be at least 18 years of age at the time of signing the informed co... [+5]

Systemic anti cancer therapy within 4 weeks of first dose of study drug [+3]

Read more
Status: Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity to determine the preliminary recommended dose for expansion (RDE) of NKT3964 in adults with advanced or metastatic solid tumors. The goal of the Expansion phase of the study is to evaluate the preliminary anti-tumor activity of NKT3964 at the RDE based on objective response rate (ORR) and determine the preliminary recommended Phase 2 dose (RP2D).

Participants needed: 150
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: NiKang Therapeutics, Inc.Updated: Apr 21, 2026Locations: 19
Eligibility criteria

Ovarian cancer [+10]

Locally advanced solid tumor that is a candidate for curative treatment through... [+13]

Read more